Improving Multiple Sclerosis treatment outcomes

改善多发性硬化症的治疗效果

• 批准号: nhmrc : GNT1080518
• 负责人: Prof Helmut Butzkueven
• 金额: $ 39.4万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Practitioner Fellowships
• 财政年份: 2015
• 资助国家: 澳大利亚
• 起止时间: 2015-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/improving-multiple-sclerosis-treatment-outcomes/1345357
• 关键词: Improving; Multiple; Sclerosis; treatment; outcomes

Multiple Sclerosis (MS) is an autoimmune disease often diagnosed in early adulthood. Outcomes very enormously, from mild to disabling. This fellowship supports research to improve outcome prediction using genetics and to examine different strategies to optimise treatment outcomes and safety. The main data source is MSBase, which tracks over 31000 people with MS globally and is based in the University of Melbourne's brain Centre at the Royal Melbourne Hospital.

多发性硬化症（MS）是一种自身免疫性疾病，通常在成年早期诊断。后果非常严重，从轻微到致残。该奖学金支持使用遗传学改善结果预测的研究，并检查不同的策略以优化治疗结果和安全性。主要的数据来源是MSBase，它追踪全球超过31000名MS患者，位于皇家墨尔本医院的墨尔本大学大脑中心。